Vienna - Delayed Quote EUR
argenx SE (ARGX.VI)
530.20
+4.60
+(0.88%)
At close: April 24 at 3:30:16 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in EUR | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 17 | 17 | 27 | 26 |
| Avg. Estimate | 737.13M | 799.22M | 3.3B | 4.26B |
| Low Estimate | 695.61M | 669.41M | 2.94B | 3.61B |
| High Estimate | 816.47M | 887.16M | 3.74B | 5.37B |
| Year Ago Sales | 383.84M | 450.91M | 2.14B | 3.3B |
| Sales Growth (year/est) | 92.04% | 77.25% | 54.14% | 28.83% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ARGX.VI | -- | -- | -- | -- |
| S&P 500 | 6.94% | 4.52% | 8.32% | 14.18% |
Related Tickers
8E8.MU Elicera Therapeutics AB
0.3040
0.00%
PHM.VI Pharma Mar, S.A.
81.30
+1.82%
UNC.F UCB SA
146.20
+2.60%
CNTA Centessa Pharmaceuticals plc
13.61
+4.45%
UCB.BR UCB SA
147.35
+0.41%
ITOS iTeos Therapeutics, Inc.
7.46
+4.34%
ACLX Arcellx, Inc.
63.97
+0.53%
IOBT IO Biotech, Inc.
0.9228
-1.83%
ZNTL Zentalis Pharmaceuticals, Inc.
1.5100
+0.67%
CRNX Crinetics Pharmaceuticals, Inc.
33.39
+3.15%